---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Paratus"
developer_entity: "A. Menarini Industrie Farmaceutiche Riunite Srl."
bundle_id: "com.menarini.congressapp"
app_store_id: "6449779457"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-06-13"
report_date: "2026-09-08"
last_verified: "2026-09-08T00:00:00.000Z"
report_version: "1.3.0"
total_reviews: 0
confidence: "low"
confidence_score: 0.05
data_age_days: 62
momentum_velocity: "zombie"
intelligence_version: 3
tags: ["medical", "free", "mobile app", "app review", "app analysis", "medical", "professionals", "healthcare"]
canonical_url: "https://marlvel.ai/apps/paratus"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Paratus Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free

> **TL;DR:** Paratus is a medical app by A. Menarini Industrie Farmaceutiche Riunite Srl., available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Paratus is a medical app by A. Menarini Industrie Farmaceutiche Riunite Srl..
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | A. Menarini Industrie Farmaceutiche Riunite Srl. |
| **Pricing** | Free |
| **Platforms** | iOS |
| **Confidence** | Low (0.05/1.0) |
| **Data Age** | 62d |

## Metadata & Market Performance
- **Publisher:** A. Menarini Industrie Farmaceutiche Riunite Srl.
- **Category:** Medical
- **Target Audience:** Medical professionals and healthcare providers attending scientific congresses.
- **Platforms:** iOS
- **Version Reviewed:** 1.3.0
- **Report Date:** 2026-09-08
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.05/1.0)
- **App Store ID (iOS):** 6449779457
- **Bundle ID:** com.menarini.congressapp
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-09-08

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Paratus is a medical-scientific event utility for healthcare professionals on iOS, providing access to congress programs, logistics, and regulatory codes of conduct.
**Why users hire it:** The platform removes the cognitive friction of managing fragmented travel, scientific, and deontological documentation during high-stakes medical congresses.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Event Logistics Dashboard:** Centralized repository for event dates, venue addresses, and transportation schedules.
- **[Standard] Scientific Program Management:** Digital access to congress agendas, satellite sessions, and speaker lists.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Regulatory and Deontological Guidance:** Reference section for medical codes of conduct and travel documentation, mitigating compliance risk.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Paratus occupies a specialized niche in the Medical category, serving as a B2B-funded utility rather than a consumer-facing product. The lack of updates for over 450 days suggests a static position that relies on event-specific distribution rather than organic store growth.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free access for medical professionals
- **Analysis:** The platform functions as a free utility for event attendees, funded by the sponsoring pharmaceutical company.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Regulatory guidance section mitigates pharmaceutical compliance risk

**Growth Levers:**
- Real-time push notifications for session updates


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The platform's strategic outlook shifted from competitive vulnerability to technical maintenance risk, prioritizing OS compatibility audits over feature-based engagement.

**Overall trend**: Stable
**Compared at**: 2026-09-08

### High-impact changes
- **[Shifted] PM Action Priority** (positioning)

### Medium-impact changes
- **[Shifted] Threat Profile Refinement** (swot)
- **[Shifted] Outlook Trend** (positioning)

<!-- section:whats-new -->
## What's New

- **Latest (v1.3.0, 1 years ago):** Introduced a dedicated event feed for the foundation.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Quiet 15 months, no feature expansion.
- Last major release June 2025.

> **Cadence:** 1 total versions · 1 majors in last 6 months · 452 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Paratus is a medical app that is completely free.

<!-- speakable-start -->
> **Bottom Line:** Paratus provides essential compliance and logistical utility for medical congress attendees, but the 15-month development silence risks technical obsolescence against more agile, general-purpose event platforms.
<!-- speakable-end -->

**Best for:** Medical professionals and healthcare providers attending scientific congresses.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [MAINTAIN] Audit current codebase for OS compatibility because the 15-month release gap risks technical failure → maintain platform stability
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The market for medical event utilities is shifting toward integrated, real-time communication tools. Paratus remains stable but exposed, as its static feature set may fail to meet the expectations of professionals accustomed to high-cadence, interactive event apps.

- ⚪ The 15-month development silence suggests the platform is in maintenance mode, serving specific events rather than pursuing broad user growth.
- 🔴 Lack of recent updates increases the risk of technical failure on newer mobile operating systems, potentially eroding the utility for medical professionals.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Trend | Stable |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Paratus** (this app) | N/A/5 | N/A | A. Menarini Industrie Farmaceutiche Riunite Srl. |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** A. Menarini Industrie Farmaceutiche Riunite Srl.

## Data Sources & Links
- **App Store ID:** 6449779457
- **Sources:** App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 62 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/paratus)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.